Latest News

In March 2026, The Descartes Systems Group Inc. reported full-year revenue of US$728.99 million and net income of US$163.77 million, alongside a CFO transition and completion of a small US$0.9 million share repurchase program. The company also highlighted expanded AI capabilities in its Global Logistics Network, with OpsForce automating freight visibility and documentation workflows across hundreds of thousands of drivers. We’ll now examine how Descartes’ record earnings and expanded...

Fresh Del Monte Produce (FDP) has been in focus after mixed Q4 results highlighted modest sales growth, strong cash generation, thin margins, and weather related cost pressures, along with a recent insider share sale. See our latest analysis for Fresh Del Monte Produce. At a latest share price of $41.38, Fresh Del Monte Produce has seen an 8.9% 90 day share price return and a 41.2% 1 year total shareholder return, suggesting momentum has been building even as mixed Q4 results and insider...

SiriusPoint (SPNT) is reshaping its operations into four business areas, including a combined Global P&C Programs division and a new London Market Specialty unit, signaling a fresh focus on programs and London specialty lines. See our latest analysis for SiriusPoint. The reorganization comes after a softer recent patch for the stock, with a 90 day share price return of a 7.24% decline and a year to date share price return of a 3.37% decline. This is in contrast with the 1 year total...

Tango Therapeutics, Inc. has reported fourth-quarter 2025 net loss of US$38.75 million and a full-year 2025 net loss of US$101.59 million, alongside full-year revenue of US$62.38 million, while also filing a US$95.67 million common stock shelf registration related to its employee stock ownership plan. Erasca, Inc.’s recent clinical trial collaboration and supply agreement with Tango to combine ERAS-0015 and vopimetostat in MTAP-deleted pancreatic and lung cancers adds an additional layer of...

Why the latest earnings report matters for National Vision Holdings (EYE) National Vision Holdings (EYE) just posted quarterly and full year results that moved from a prior net loss to a profit, paired with revenue growth, fresh guidance, and new store expansion plans. See our latest analysis for National Vision Holdings. At a share price of US$26.28, the stock has seen short term pressure, with a 30 day share price return of 6.87% and a 90 day share price return of 8.11%. A 1 year total...

In March 2026, Campbell’s reported softer second-quarter and first-half results, with sales and net income lower than a year earlier, alongside reduced fiscal 2026 guidance and continued weakness in its snacks and bakery businesses. At the same time, Campbell’s has been reshaping its leadership and capital allocation, appointing new heads of supply chain and investor relations while selectively executing share repurchases under two ongoing buyback programs. We’ll now examine how the weaker...

Earlier in March 2026, ProPetro Holding reported quarterly results that beat analyst expectations and showed a move back into profitability, while crude oil prices climbed sharply following renewed attacks on Middle East energy infrastructure that raised concerns about supply disruptions. This combination of stronger operating performance and a supportive commodity backdrop highlighted how closely ProPetro’s prospects are tied to both execution and broader geopolitical tensions in energy...

Nabors Industries recently reported its fourth-quarter 2025 results, posting adjusted profit of US$0.17 per share and higher operating revenue year over year, driven by stronger contributions from its International Drilling and Drilling Solutions segments. An interesting aspect of this report is how improved free cash flow generation and segment performance have encouraged analysts to revise their estimates upward and assign a more optimistic outlook for the company. Now we’ll examine how...

Akeso (SEHK:9926) is back in focus after announcing that its trispecific antibody AK150 has received IND clearance from China’s NMPA, clearing the way for clinical trials in advanced solid tumors. See our latest analysis for Akeso. The AK150 IND clearance, together with recent cervical cancer data for cadonilimab and the GBM collaboration announcement, has coincided with a 5.81% 1 day share price return and a 12.44% 7 day share price return at a current share price of HK$116.6. The 1 year...

Why Pebblebrook Hotel Trust (PEB) is on investors’ radar today Pebblebrook Hotel Trust (PEB) has drawn investor attention following recent share price moves, with the stock down about 2% over the past week and about 9% over the past month. In this context, the REIT’s latest disclosed revenue of US$1,475.544 million and a reported net loss of US$105.757 million provide a clearer snapshot of the current business profile and risk level. See our latest analysis for Pebblebrook Hotel...

Millrose Properties (MRP) has attracted investor attention after recent share price pressure, with the stock down about 11% over the past month and roughly 8% over the past 3 months. See our latest analysis for Millrose Properties. Despite the recent share price pressure, with the latest share price at $28.30 and a 30 day share price return of an 11% decline, Millrose Properties still has a 1 year total shareholder return of 40.32%, which suggests that recent momentum is fading after a...

InnoCare Pharma recently dosed the first healthy volunteer in a China clinical trial of ICP-538, an oral VAV1-directed molecular glue degrader for autoimmune diseases, marking the first VAV1 degrader to reach trials in China and only the second globally. This move positions InnoCare at the forefront of a new class of targeted immunology drugs, in an area where no VAV1-focused therapies are yet approved worldwide. We’ll now examine how advancing ICP-538, a first-in-China VAV1 degrader, could...

Why Republic Services (RSG) Is Back on Investor Radar Republic Services (RSG) is drawing fresh attention after several research firms issued more positive outlooks and institutional investors lifted their positions, following strong Q4 results and upbeat 2026 guidance. Alongside this, the company is emphasizing margin expansion and rolling out electric vehicles, while leaning on its essential waste and recycling services, which has contributed to a shift in overall sentiment toward the...

In early March 2026, Bank of America announced upcoming redemptions of several billion in senior notes while simultaneously issuing a range of new fixed‑income securities and confirming regular cash dividends across multiple preferred share series. This combination of refinancing activity, preferred payouts, and high‑profile shareholder moves such as Berkshire Hathaway halving its stake has sharpened attention on how Bank of America is rebalancing its funding mix and risk profile. Next,...

In early March 2026, Asana announced a series of leadership changes, including a new Chief Financial Officer and Chief Accounting Officer, alongside fourth-quarter and full-year results showing higher revenues and lower net losses, completion of a US$210.6 million share repurchase program, and a new US$97.78 million shelf registration for employee stock offerings. Together with fresh revenue guidance for fiscal 2027 and expanded AI-driven product initiatives, these moves point to an...

In early March 2026, NTT DOCOMO, StarHub and ServiceNow announced a joint initiative to build an AI‑driven, autonomous roaming resolution model on the ServiceNow AI Platform, aiming to standardize and automate how carriers identify and fix international roaming issues for travelers. This collaboration is material because it seeks to cut manual support, improve reliability for roaming customers, and create a globally scalable, shared operational framework between mobile operators. Next, we’ll...

What Federated Hermes Stock Data Tells You Right Now Federated Hermes (FHI) is on investor watch after recent price moves, with the stock closing at US$56.99 and showing positive returns over the past week, month and past 3 months. See our latest analysis for Federated Hermes. The recent 1-day share price return of 0.78% builds on a 90-day share price return of 9.39%, while the 1-year total shareholder return of 48.13% suggests that momentum has been strong over both shorter and longer...

Earlier in March 2026, PDF Solutions reported a strong fourth-quarter 2025 performance, with revenue growth and higher gross margins following management’s update on its evolving business model and expanding role in networking and scaled analytics across the semiconductor ecosystem. An interesting angle is how PDF Solutions is increasingly positioning its analytics and networking offerings as core infrastructure for semiconductor supply-chain collaboration and manufacturing...

Hilton Grand Vacations (HGV) recently reported a fourth quarter that missed analyst expectations on revenue, EPS, and adjusted operating income. This coincided with a 13.9% slide in the share price. See our latest analysis for Hilton Grand Vacations. The disappointing quarter has weighed on recent trading, with a 1-month share price return decline of 11.55% and a year-to-date share price return decline of 10.13%, even though the 1-year total shareholder return is 11.09%. The earnings miss...

Recent quarterly results from Bio-Techne (TECH) came in ahead of earnings and revenue forecasts, and were followed by fresh institutional buying and portfolio additions that put renewed attention on the life sciences supplier. See our latest analysis for Bio-Techne. Despite the upbeat quarter and renewed institutional interest, the 30 day share price return of a 15.15% decline and 1 year total shareholder return of an 18.27% loss show momentum has been weak, with pressure building across both...

Keymed Biosciences (SEHK:2162) is back in focus after partner AstraZeneca began a Phase III trial of CMG901 in advanced gastric and related cancers, triggering a US$45 million milestone payment to the group. See our latest analysis for Keymed Biosciences. The CMG901 Phase III update comes after a strong 1 year total shareholder return of 50.97%. Shorter term share price momentum is steadier, with a 7 day share price return of 6.36% around the HK$54.35 level. If you are looking for other...

China Mengniu Dairy (SEHK:2319) has issued preliminary 2025 guidance flagging a 7% to 8% revenue decline and a slightly lower operating margin, while also being removed from the Hang Seng China Enterprises Index. See our latest analysis for China Mengniu Dairy. The latest guidance and index removal come after a mixed share price pattern, with a 12.1% year to date share price return and a 12.5% 90 day share price return, but a 13.0% negative total shareholder return over the past year. This...

Gaztransport & Technigaz (GTT) recently received an order from HD Korea Shipbuilding & Offshore Engineering for the LNG tank design of a Sonangol-owned carrier, to be built at HD Hyundai Samho and equipped with GTT’s Mark III Flex membrane containment system for delivery in the second quarter of 2028. This contract highlights continued adoption of GTT’s containment technology by leading Korean yards and reinforces its role in upcoming LNG shipping projects. We’ll now examine how this new LNG...

Why Dream Industrial REIT's new buyback is catching investor attention Dream Industrial Real Estate Investment Trust (TSX:DIR.UN) has launched a normal course issuer bid that allows it to repurchase and cancel up to 28,272,244 units, or 9.95% of outstanding units, through March 9, 2027. See our latest analysis for Dream Industrial Real Estate Investment Trust. The buyback arrives after a mixed stretch for the units, with a 3.86% 90 day share price return and a 15.51% 1 year total shareholder...